Zura Bio ZURA
NASDAQ ZURA
$4.11 -0.03 (-0.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zura Bio (ZURA) Non-Current Deffered Revenue (2021 - 2022)

Updated

Zura Bio's Non-Current Deffered Revenue came in at $4.01 million for Q4 2022, unchanged from $4.01 million a year earlier and unchanged from the prior quarter.

Analysis

Zura Bio (ZURA) Non-Current Deffered Revenue (2021 - 2022) Analysis & Trends

Going back to Q4 2021, Zura Bio's Non-Current Deffered Revenue data covers 5 quarters.

  • Going back by year, Non-Current Deffered Revenue was $4.01 million in FY2021.
  • Business Quant data shows ZURA's Non-Current Deffered Revenue at $4.01 million (Q3 2022), $4.01 million (Q2 2022) and $4.01 million (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Zura Bio 521.16 Mn 521.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 4.01 Mn
Sep 30, 2022 4.01 Mn
Jun 30, 2022 4.01 Mn
Mar 31, 2022 4.01 Mn
Dec 31, 2021 4.01 Mn
API Access

Zura Bio Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZURA&period=max&api_key=YOUR_API_KEY